The literature on risk factors for cardiometabolic diseases showed that lutein might be beneficial for atherosclerosis and inflammatory markers , but there were inconsistent associations with blood pressure , adiposity , insulin resistance , and blood lipids .
CONCLUSIONS Our findings suggest that higher dietary intake and higher blood concentrations of lutein are generally associated with better cardiometabolic health .
BACKGROUND The antioxidant lutein is suggested as being beneficial to cardiometabolic health because of its protective effect against oxidative stress , but evidence has not systematic ally been evaluated .
OBJECTIVE We aim ed to evaluate systematic ally the effects of lutein ( intake or concentrations ) on cardiometabolic outcomes in different life stages .
Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?
BACKGROUND the evidence of a potential beneficial role of antioxidants in preventing atherosclerotic disease is not entirely consistent . OBJECTIVE to assess the longitudinal association of serum total antioxidant capacity and serum antioxidants with the presence of sub clinical carotid atherosclerosis . METHODS Prospect i ve case-control study nested within an historical cohort . Cases were 150 individuals with elevated carotid intimal-medial thickness measured by B-mode ultrasound at the first two examinations of the Atherosclerosis Risk in Communities Study ( 1987 - 92 ) . Controls were 150 age-gender-matched individuals with low carotid intimal-medial thickness .  Serum antioxidant vitamins , uric acid , and serum total antioxidant capacity  were measured in frozen serum sample s collected from the same  individuals  in 1974 ( 13 - 15 years prior to the determination of case-control status ) . RESULTS Compared to controls , atherosclerosis cases had significantly higher levels of serum total antioxidant capacity in 1974 than controls . This difference was almost entirely explained by increased serum concentration of uric acid in cases . In contrast with cross-sectional results , uric acid serum concentration in 1974 , was significantly higher in cases than in controls , even after adjusting for the main cardiovascular risk factors . Cases had significantly lower levels of alpha-carotene in the 1974 sera than controls , but no other differences in serum antioxidant vitamin concentrations were observed . CONCLUSIONS The higher serum uric acid concentration seemed associated with elevated total serum antioxidant capacity among individuals with atherosclerosis . This finding is consistent with experimental evidence suggesting that hyperuricemia may be a compensatory mechanism to counteract oxidative damage related to atherosclerosis and aging in humans
The literature on risk factors for cardiometabolic diseases showed that lutein might be beneficial for atherosclerosis and inflammatory markers , but there were inconsistent associations with blood pressure , adiposity , insulin resistance , and blood lipids .
CONCLUSIONS Our findings suggest that higher dietary intake and higher blood concentrations of lutein are generally associated with better cardiometabolic health .
BACKGROUND The antioxidant lutein is suggested as being beneficial to cardiometabolic health because of its protective effect against oxidative stress , but evidence has not systematic ally been evaluated .
OBJECTIVE We aim ed to evaluate systematic ally the effects of lutein ( intake or concentrations ) on cardiometabolic outcomes in different life stages .